1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Histopathologic diagnosis distributed by tumor grade
HistologyGrade IIGrade IIIGrade IVTotal
Astrocytomas15 (11.9%)7 (5.6%)73 (57.9%) (GBM)95 (75.4%)
Oligodendrogliomas8 (6.3%)10 (7.9%)18 (14.2%)
Oligoastrocytomas3 (2.4%)3 (2.4%)7 (5.6%) (GBM-O)13 (10.4%)
Total26 (20.6%)20 (15.9%)80 (63.5%)126 (100%)
  • Note:—GBM indicates glioblastoma multiforme; GBM-O, glioblastoma with oligoastrocytoma grade IV.